NCT03385720Recruiting
Submandibular Gland Preservation in Neck Dissection
Submandibular Gland Preservation During Neck Dissection for Oral Squamous Cell Carcinoma
Source: ClinicalTrials.gov · Last updated 30 Mar 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Trial design: a randomized controlled trial. Eligibility criteria for participants: patients with primary early stage oral squamous cell carcinoma. Exclusion criteria: cancer of the floor of the mouth. Interventions: submandibular gland is preserved during neck dissection for patients of the experimental group; submandibular gland is removed during neck dissection for patients of the control group. Primary Parameters: survival rate, mortality rate
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 6 Dec 2017
- Start date
- 5 Dec 2017
- Primary completion date
- Dec 2023
- Lead sponsor
- Guang-Yan Yu
- Diseases
- Childhood cancers
- NCT number
- NCT03385720
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 5 Dec 2017 to the primary completion date, Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cancer of the floor of the mouth.
Who the study is looking for
- Primary oral squamous cell carcinoma of early stage (T1N0 and T2N0).
Age in the registry: - to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University School of Stomatology Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.